ORAMED PHARMACEUTICALS INC. (ORMP) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$2.0M

Net Income/Loss (FY2025)

$64.0M

Total Assets (FY2025)

$230.9M

Total Equity (FY2025)

$199.7M

Cash Flows from Operating Activities (FY2025)

-$9.1M

Source: ORAMED PHARMACEUTICALS INC. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.